Breast cancer is overwhelmingly the most common malignancy of women. Despite substantial efforts, incidence rates and mortality rates have not changed significantly. New therapeutic approaches are clearly needed. Our goals are to develop new treatment strategies for human breast cancer which are derived from an in depth analysis of cellular and molecular events that control mitogenesis and malignant progression. Specifically, a variety of critical steps involved in the breast cancer process will be examined in detail. In program one information on regulation of gene expression by estrogens as well as regulation of expression of steroid and polypeptide receptors for growth factors will be investigated. Specific focus will be paid to the retinoblastoma gene and its role in breast cancer progression. A series of approaches aimed at interrupting signal transduction pathways that lie between ligand binding to cell surface receptor and specific phenotypic effects leading to malignant progression will be the subject of program area two. In program area three, a series of models which mimic the progression of human breast cancer from the hormone dependent phenotype to hormone unresponsiveness will be further explored along with several approaches geared towards blocking this progression. We have substantial preliminary information that suggests that heparin binding growth factors play an important role in epithelial transformation of human breast cancer. We have designed several strategies to interrupt the activity of these growth factors and their exploitation as antitumor therapies will be explored in program area four. Finally, in program area five we will study the control of invasiveness of breast cancer modulated through cell surface proteases. A series of strategies designed to further understand the cellular and molecular biology of these critical regulators of the metastatic phenotype as well as several approaches to their inhibition will be developed as potential antimetastatic therapies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA051908-02
Application #
3549506
Study Section
Special Emphasis Panel (SRC (40))
Project Start
1990-05-21
Project End
1995-04-30
Budget Start
1991-05-01
Budget End
1992-04-30
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Leonessa, F; Green, D; Licht, T et al. (1996) MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer. Br J Cancer 73:154-61
Dickson, R B; Johnson, M D; Maemura, M et al. (1996) Anti-invasion drugs. Breast Cancer Res Treat 38:121-32
Ruiz-Cabello, J; Berghmans, K; Kaplan, O et al. (1995) Hormone dependence of breast cancer cells and the effects of tamoxifen and estrogen: 31P NMR studies. Breast Cancer Res Treat 33:209-17
Maemura, M; Akiyama, S K; Woods Jr, V L et al. (1995) Expression and ligand binding of alpha 2 beta 1 integrin on breast carcinoma cells. Clin Exp Metastasis 13:223-35
Martin, M B; Garcia-Morales, P; Stoica, A et al. (1995) Effects of 12-O-tetradecanoylphorbol-13-acetate on estrogen receptor activity in MCF-7 cells. J Biol Chem 270:25244-51
Giunciuglio, D; Culty, M; Fassina, G et al. (1995) Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes. Int J Cancer 63:815-22
Leonessa, F; Jacobson, M; Boyle, B et al. (1994) Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, and M(r) 170,000 glycoprotein (gp170) binding studies. Cancer Res 54:441-7
Maemura, M; Dickson, R B (1994) Are cellular adhesion molecules involved in the metastasis of breast cancer? Breast Cancer Res Treat 32:239-60
Thompson, E W; Yu, M; Bueno, J et al. (1994) Collagen induced MMP-2 activation in human breast cancer. Breast Cancer Res Treat 31:357-70
Clarke, R; Skaar, T; Baumann, K et al. (1994) Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression. Breast Cancer Res Treat 31:237-48

Showing the most recent 10 out of 28 publications